List view / Grid view
Stem cells are undifferentiated biological cells that can differentiate into specialised cells and can divide to produce more stem cells.
This webinar explains how synthetic guide RNAs are stable, eliminate cloning and sequencing steps, and avoid innate immune responses and cytotoxicity.
This article explains how to plan a gene-editing experiment. How to choose your biological system and what reagents to get for your experimental aim.
Intestinal organoids have been grown by researchers using stem cells from patient tissues that could lead to personalised transplants for children with intestinal failure.
Researchers have discovered compounds able to restart production of VEGF-A in cellular models, which rebuilds blood vessels and muscle in damaged heart tissue.
A new study has shown that 3D printing can be used to control stem cell differentiation into embryoid bodies that replicate heart cells.
A UK company has announced that their lung epithelium model can successfully be used to test potential treatments for COVID-19.
As more of the small devices in the lab become connected, more laboratory workflows will be observable, and variability will be better understood.
Learn how one lab is saving time, improving traceability, and standardising protocols by using connected tools and recording all workflows digitally.
Mass production with iPSCs: how Ncardia has pushed the boundaries with high-throughput iPSC research.
Neuroinflammation study by combining human iPSC-derived astrocytes and HTRF.
Get reproducible and quantitative count, size, morphology and particle ID in one system with the Aura™.
Controlled manufacturing of hiPSC-derived cardiomyocytes in stirred-tank bioreactors enabling high-throughput phenotypic screening.
This Ncardia company presentation will explain how human stem cell technology offers a solution for drug screening as well as cell therapy projects.
Protein Or not? Advanced high throughput aggregate analysis with The Aura™ - Find the problem before it happens particle analysis reimagined.
26 June 2020 | By Tecan
This webinar described the recent efforts to identify small molecule therapeutics for the treatment of SARS-CoV-2 infection and COVID-19 disease.
